e-learning
resources
ERJ
2015
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Telomeres revisited: RTEL1 variants in pulmonary fibrosis
Kropski Jonathan A., Loyd James E.
Source:
Eur Respir J 2015; 46: 312-314
Journal Issue:
August
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Kropski Jonathan A., Loyd James E.. Telomeres revisited: RTEL1 variants in pulmonary fibrosis. Eur Respir J 2015; 46: 312-314
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Serum KL-6 as a biomarker for interstitial lung diseases in a clinical setting: application of a fully automated immunoassay.
The cryoTBB role in the diagnostic work-up of IPF: an European perspective; emergent standardization guidelines
Acute exacerbations of IPF: A neglected threat in IPF ?
Related content which might interest you:
Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis
Source: Eur Respir J 2015; 46: 474-485
Year: 2015
Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis
Source: Eur Respir J 2016; 48: 1721-1731
Year: 2016
Combined pulmonary fibrosis and emphysema syndrome associated with ABCA3 mutations
Source: Eur Respir J 2014; 43: 638-641
Year: 2013
Regulator of telomere length 1 (
RTEL1
) mutations are associated with heterogeneous pulmonary and extra-pulmonary phenotypes
Source: Eur Respir J, 53 (2) 1800508; 10.1183/13993003.00508-2018
Year: 2019
The study of telomere associated genes and telomere measurement in Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020
Novel rare genetic variants in idiopathic pulmonary fibrosis
Source: Eur Respir J, 56 (6) 2003252; 10.1183/13993003.03252-2020
Year: 2020
Novel biomarkers in bleomycin-induced pulmonary fibrosis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013
Pulmonary fibrosis associated with TINF2 gene mutation: is somatic reversion required?
Source: Eur Respir J 2014; 44: 270-271
Year: 2014
Pulmonary fibrosis associated with TINF2 gene mutation: is somatic reversion required?
Source: Eur Respir J 2014; 44: 269-270
Year: 2014
Pulmonary fibrosis in non-mutation carriers of families with short telomere syndrome gene mutations.
Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis
Year: 2021
Familial pulmonary fibrosis: Respiratory function progression analysis in different HRCT patterns
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015
Cystic fibrosis related pulmonary disease: more structure than function?
Source: Eur Respir J 2005; 26: Suppl. 49, 729s
Year: 2005
MiR-214-3p, a new fibromiR involved in the pathogenesis of idiopathic pulmonary fibrosis
Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis
Year: 2014
Role of midkine in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
Serum IGFBP2 as a marker of idiopathic pulmonary fibrosis
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Plasma protein signature of idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013
First heterozygous
NOP10
mutation in familial pulmonary fibrosis
Source: Eur Respir J, 55 (6) 1902465; 10.1183/13993003.02465-2019
Year: 2020
Pulmonary expression of alternatively spliced tissue factor as a potential prognostic marker in idiopathic pulmonary fibrosis
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Distinct clinical and pathological phenotypes in IPF
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept